A Multicenter, Randomized, Naturalistic, Open-Label Study Between Aripiprazole and Standard of Care in the Management of Community-Treated Schizophrenic Patients (Schizophrenia Trial of Aripiprazole - STAR)
Latest Information Update: 12 Nov 2013
Price :
$35 *
At a glance
- Drugs Aripiprazole (Primary) ; Olanzapine; Quetiapine; Risperidone
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- Acronyms STAR
- Sponsors Bristol-Myers Squibb
- 14 Apr 2011 Actual end date (1 Aug 2005) added as reported by ClinicalTrials.gov.